Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Occludin anticorps (AA 282-415)

OCLN Reactivité: Humain IHC (f) Hôte: Souris Monoclonal OCLN-2183 unconjugated
N° du produit ABIN6939018
  • Antigène Voir toutes Occludin (OCLN) Anticorps
    Occludin (OCLN)
    Épitope
    • 16
    • 16
    • 15
    • 9
    • 7
    • 6
    • 5
    • 4
    • 4
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 282-415
    Reactivité
    • 105
    • 66
    • 46
    • 34
    • 18
    • 13
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    Humain
    Hôte
    • 87
    • 20
    • 3
    • 1
    Souris
    Clonalité
    • 85
    • 26
    Monoclonal
    Conjugué
    • 47
    • 10
    • 7
    • 6
    • 5
    • 4
    • 4
    • 4
    • 4
    • 4
    • 4
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    Cet anticorp Occludin est non-conjugé
    Application
    • 89
    • 34
    • 29
    • 26
    • 26
    • 17
    • 15
    • 15
    • 12
    • 8
    • 7
    • 2
    • 2
    • 1
    • 1
    Immunohistochemistry (Formalin-fixed Sections) (IHC (f))
    Specificité
    Occludin is a tetraspan integral membrane protein in epithelial and endothelial tight junction (TJ) structures that can contain two extracellular loops. The protein exists in a variety of phosphorylated forms. Phosphorylation is involved in regulating both the localization and the function of Occludin. Expression of Occludin is upregulated by polyunsaturated fatty acids, increasing trans-endothelial cell resistance and reducing cellular permeability to large molecules. The level of Occludin varies greatly depending on tissue, in brain tissue, Occludin is highly expressed at cell-cell contact sites. Non-neural tissues show lower expression and discontinuous distribution. Up-regulation of epithelial Occludin may play a role in enhancing paracellular permeability and be related to the damage to the tight junction.
    Réactivité croisée (Details)
    Human,
    Purification
    200ug/ml of Ab Purified from Bioreactor Concentrate by Protein A/G.
    Immunogène
    Recombinant human Occludin fragment around aa 282-415 (Exact sequence is proprietary)
    Clone
    OCLN-2183
    Isotype
    IgG1
    Top Product
    Discover our top product OCLN Anticorps primaire
  • Indications d'application

    Positive Control: HepG2 cells. Kidney.

    Known Application: Immunohistochemistry (Formalin-fixed) (1-2 μg/mL for 30 minutes at RT)(Staining of formalin-fixed tissues requires heating tissue sections in 10 mM Tris with 1 mM EDTA, pH 9.0, for 45 min at 95°C followed by cooling at RT for 20 minutes), Optimal dilution for a specific application should be determined.

    Restrictions
    For Research Use only
  • Concentration
    200 μg/mL
    Buffer
    Prepared in 10 mM PBS with 0.05 % BSA and 0.05 % azide.
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    4 °C,-80 °C
    Stockage commentaire
    Antibody with azide - store at 2 to 8 °C. Antibody is stable for 24 months. Non-hazardous. Also available WITHOUT BSA & azide at 1.0mg/ml.
    Date de péremption
    24 months
  • Antigène
    Occludin (OCLN)
    Autre désignation
    OCLN (OCLN Produits)
    Synonymes
    anticorps AI503564, anticorps Ocl, anticorps ocln, anticorps oclnb, anticorps tpmt, anticorps OCLN, anticorps wu:fd23h10, anticorps wu:fi13c01, anticorps zgc:113992, anticorps zgc:56359, anticorps BLCPMG, anticorps occludin, anticorps occludin S homeolog, anticorps occludin a, anticorps Ocln, anticorps OCLN, anticorps ocln.S, anticorps ocln, anticorps oclna
    Sujet
    BLCPMG, Occludin, OCLN, Phosphatase 1 regulatory subunit 115, PPP1R115, PTORCH1, Tight junction protein occludin,Occludin (OCLN) (Tight Junctions Marker)
    Cellular localisation: Cell Surface and Cytoplasmic
    Poids moléculaire
    60-82kDa
    ID gène
    100506658, 592605
    UniProt
    Q16625
    Pathways
    Cell-Cell Junction Organization, Hepatitis C
Vous êtes ici:
Support technique